This orchestra of factors and cell interactions synergize with both CD4 (86–88) and CD8 (89–92) T cells, enhancing their regulatory/suppressive function and contributing to a negative regulation of competent host anti-tumor T cells. Here, CD8A is linked to neoplasm.